文献速递卫生政策与健康促进免疫规划传染病防控与疫情报告

疫苗,激发健康创新

Vaccines, inspiring innovation in health.
PubMed 文献 · Vaccine · 2018-05-19

本文报道了发展中国家疫苗制造商网络(DCVMN)第18届年度大会的讨论内容,涵盖大流行与流行病应对、合作伙伴关系、监管趋同倡议、新技术与新型疫苗。全球疫苗免疫联盟(Gavi)和新兴国家疫苗产业贡献了58%的剂量。会议还讨论了疫苗储备优先事项、全球疫苗可及性、采购与免疫覆盖,以及世界卫生组织(WHO)的预认证和监管趋同建议。

要点

  • 发展中国家疫苗制造商网络(DCVMN)第18届年度大会讨论了大流行、流行病与合作伙伴关系等议题。
  • 全球疫苗免疫联盟(Gavi)和新兴国家疫苗产业贡献了全球疫苗市场58%的剂量。
  • 会议讨论了疫苗储备优先事项、全球疫苗可及性、采购与免疫覆盖,以及世界卫生组织(WHO)的预认证和监管趋同建议。

核心结论

  • 会议讨论使成员和合作伙伴得以反思研发效率、供应链工具和包装技术趋势,并加深对当前公共卫生目标、行业融资和全球政策的理解。

研究设计与样本

  • 本文为发展中国家疫苗制造商网络(DCVMN)第18届年度大会(AGM)的报告,汇集了公共和私营部门主要利益相关方的讨论。

主要发现

  • 全球疫苗免疫联盟(Gavi)和新兴国家疫苗产业通过改善发展中国家制造商的供应基础,贡献了58%的剂量。
  • 流行病防范创新联盟(CEPI)、国际疫苗研究所(IVI)等报告了确保未来中东呼吸综合征(MERS)、寨卡或其他疫情应对的创新疫苗临床前和临床开发快速进展的新策略。
  • 会议概述了疫苗储备优先事项,以确保紧急情况下的准备就绪并预防黄热病、霍乱和脊髓灰质炎等再发疾病引起的疫情。
  • 世界卫生组织(WHO)和其他国际合作伙伴提供了产品、价格和采购数据库、疫苗预认证、被忽视热带病控制(特别是新的狂犬病消除倡议)以及加速发展中国家疫苗注册的监管趋同建议的最新情况。
  • 会议介绍了供应链创新和新型疫苗平台的最新进展。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This report covers the topics of pandemics, epidemics and partnerships, including regulatory convergence initiatives, new technologies and novel vaccines, discussed by leading public and private sector stakeholders at the 18th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufacturers' Network (DCVMN). Contributions of Gavi and the vaccine industry from emerging countries to the growing global vaccine market, by improving the supply base from manufacturers in developing countries and contributing to 58% of doses, were highlighted. The Coalition for Epidemic Preparedness Innovations (CEPI), the International Vaccine Institute (IVI) and others reported on new strategies to ensure speedy progress in preclinical and clinical development of innovative vaccines for future MERS, Zika or other outbreak response. Priorities for vaccine stockpiling, to assure readiness during emergencies and to prevent outbreaks due to re-emerging diseases such as yellow fever, cholera and poliomyelitis, were outlined. The role of partnerships in improving global vaccine access, procurement and immunization coverage, and shared concerns were reviewed. The World Health Organization (WHO) and other international collaborating partners provided updates on the Product, Price and Procurement database, the prequalification of vaccines, the control of neglected tropical diseases, particularly the new rabies elimination initiative, and regulatory convergence proposals to accelerate vaccine registration in developing countries. Updates on supply chain innovations and novel vaccine platforms were presented. The discussions enabled members and partners to reflect on efficiency of research & development, supply chain tools and trends in packaging technologies improving delivery of existing vaccines, and allowing a deeper understanding of the current public-health objectives, industry financing, and global policies, required to ensure optimal investments, alignment and stability of vaccine supply in developing countries.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Pagliusi S, Dennehy M, Kim H, et al. Vaccines, inspiring innovation in health. Vaccine. 2018. PMID: 29789241. doi:10.1016/j.vaccine.2018.05.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。